• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • scientific magazine yafte
    • Volume 9, Issue 4
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • scientific magazine yafte
    • Volume 9, Issue 4
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    An Evaluation of the Effects of Oral Carnitine in Decreasing Complications of Chronic Hemodialysis at Fatemieh Hospital in Semnan

    (ندگان)پدیدآور
    Tamadon, mohammad rezaToussy, jafarSoleimani, alirezaMoghimi, jamileMalek, farhadMoradi, aliShahvarani, ashrafol molokTavasoli, mohtaram
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    156.6کیلوبایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    Research
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    Tamadon MR1, Toussy J2, Soleimani AR3, Moghimi J1, Malek F1, Moradi A4, Shahvarani A5, Tavasoli M5 1. Assistant Professor, Department of Internal, Digestion and Hepatology Research Center, Semnan University of Medical Sciences 2. Statistics Counselor, Digestion and Hepatology Research Center, Semnan University of Medical Sciences 3. Assistant Professor, Department of Internal, Kashaan University of Medical Sciences 4. BSc. Nurse, Manager of Fatemieh Hospital Dialysis Ward, Semnan University of Medical Sciences 5. BSc. Nurse, Fatemieh Hospital, Semnan University of Medical Sciences Abstract Background: Chronic dialysis is an expensive procedure for patients and health care centers. If we can decrease the complications during dialysis as much as possible, so could we decrease expenses resulted from repeated dialysis. L-carnitine is a necessary agent for natural function of myocardium and skeletal muscles therefore, it may decrease different complications during dialysis. This study was performed to assess of carnitine role in this respect. Materials and methods: The patients who referred to dialysis ward of Fatemieh hospital from Jul. 2005 to Feb. 2006 were enrolled in a double blind cross-over clinical trial. All the patients were divided into two groups. The control group received placebo and the trial group received L-carnitine (500mg/d) during dialysis. The occurrence of complications resulting from dialysis in any session (including decreasing of blood pressure, cramp and vomiting) after the use of placebo and/or L-carnitine was assessed and compared in both groups. Results: Out of 33 patients who participated in the study, 26 continued to the end of the study period. Occurrence of different complications during the use of placebo and/or L-carnitine did not have any significant differences. Conclusion: It seemed that L-carnitine (500mg/d) does not have any obvious effects on dialysis patients and results in unnecessary expenses for patients, so it is not recommended.
    کلید واژگان
    L-carnitine
    chronic hemodialysis

    شماره نشریه
    4
    تاریخ نشر
    2008-02-01
    1386-11-12

    شاپا
    1563-0773
    URI
    http://yafte.lums.ac.ir/article-1-55-en.html
    https://iranjournals.nlai.ir/handle/123456789/483225

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب